Beyond Drafting Speed: What Actually Matters in AI for Medical Writing
- Dr Barry Drees
- Jun 2
- 1 min read
As AI adoption accelerates across life sciences, much of the conversation has focused on drafting speed and content generation. But are these really the metrics that matter most in regulated medical writing?
In this thought-provoking discussion, Barry Drees, PhD, Founder Advisor at TriloDocs and former President of the European Medical Writers Association (EMWA), and Louise Martinsson, PhD, Senior Director and Head of Medical Writing, Hypercare & Enablement R&D at GSK, explore the challenges and opportunities of AI in regulated documentation.
Drawing on decades of medical writing and operational leadership experience, they examine why verification, trust, reproducibility, and governance are increasingly becoming the defining factors in successful AI adoption. The discussion explores the distinction between generating content and constructing regulatory evidence, the growing importance of reducing verification burden and QC debt, and how medical writers can help shape the future of AI-enabled authoring.
Rather than asking how quickly AI can draft, this conversation asks a more important question: what does trustworthy AI look like in regulated medical writing?
Read the whole article here:
